Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $18.10 Analyst target: $19.00 Upside: 4.97%
Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.
See the full interactive analysis & chart →Informational only — not investment advice.